Abrdn Healthcare Investors (HQH)
Abrdn Healthcare Investors
1900 Market Street
Suite 200
Philadelphia, PA 19103
United States
215 405 5700
Sector(s): Financial Services
Industry: Asset Management
Full Time Employees:
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Daniel R. Omstead M.S, Ph.D. | Portfolio Manager | N/A | N/A | 1953 |
| Dr. Jason C. Akus M.B.A., M.D., MBA | Vice President of Research and Portfolio Manager | N/A | N/A | N/A |
| Mr. Christopher F. Brinzey MBA | Senior Vice President of Research and Portfolio Manager | N/A | N/A | N/A |
| Dr. Frank T. Gentile Ph.D. | Senior Vice President of Research and Portfolio Manager | N/A | N/A | 1962 |
Description
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Corporate Governance
Abrdn Healthcare Investors’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
